pharmatechoutlook
6 April - May 2018Copyright © 2018 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.APRIL - MAY 2018, Vol 04 - 02 Published by ValleyMedia Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com Editor-in-ChiefStacey SmithSalesVisualizerAsher BlakeAnil KumarEditorial StaffAaron Pierce Kuheli Biswas Ava GarciaJenna Vegas Joshua ParkerJustin SmithKatherine Joneskatherine@pharmatechoutlook.comEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comThe rise in R&D, government funding, and growth in clinical trials within the pharmaceutical and life science industry has become a driving factor for pharma companies to adopt technologies to stay at the top of their game. Clinical trials require collecting massive amounts of patient data as well as managing it while taking care of the security and quality parameters associated with the data.In fact, clinical trials require heavy supervision for successful assessment and this can be achieved through digital knowledge, patient engagement, and adoption of application software to record every minute change. In the interim, regulatory measures such as the HIPAA and the GDPR of the EU has made it necessary for researchers to employ and manage patient data with utmost care as well as streamline trial workflows seamlessly. Many players are enhancing eClinical Trial Management System (CTMS) by intersecting data management and analytics with advanced technologies such as AI and machine learning to support multiple studies together in real-time. In fact, the global eClinical solutions market work is expected to surpass 13 billion dollars and grow at a CAGR rate of 12 percent by 2024. Thus, creating an interesting competition among the CTMS providers to be at the top of the game and provide the best market solution. To enhance customer satisfaction CTMS service providers are required to customize the management system according to the client's requirements and reduce administrative cost. Furthermore, these providers have to create a robust solution that can work-around the lack of expert labors and security issues to help the market grow. It has been an interesting journey to dive into the exploration of the state-of-the-art service providers, curate the constantly changing trends, and understand how technology can help enhance management of eclinical trials. As a prelude to the unique possibilities that trial management has to offer, in this edition of Pharma Tech Outlook, we present to you a list of companies that are transforming the eclinical trial management landscape with next-generation technologies. We hope this edition will provide you with the right assistance in choosing the best-in-class solution for your requirements.Please share your thoughts with us.Building Blocks of Eclinical TrialTECH OUTLOOKTECH OUTLOOK*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffAPRIL - MAY, 2018eCLINICAL TRIAL MANAGEMENT SPECIALsales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510-996-5173, Fax:510-894-8405
< Page 5 | Page 7 >